熔点	182-183 ºC**
沸点	136.5-144.0 ºC (17 Torr)***
闪点	110.6±24.8 ºC, 计算值*
密度	0.858±0.06 g/cm3 (20 º

没有数据	没有数据

来源	SDS样本
没有数据	没有数据

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Moclobemide. An update of its pharmacological properties and therapeutic use.B Fulton et al.Drugs, 52(3), 450-474 (1996-09-01) Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide.M Mayersohn et al.Clinical pharmacokinetics, 29(5), 292-332 (1995-11-01) Serotonin toxicity caused by moclobemide too soon after paroxetine-selegiline.Ming-Ling Wu et al.Journal of the Chinese Medical Association : JCMA, 72(8), 446-449 (2009-08-19) Moclobemide: therapeutic use and clinical studies.Udo Bonnet CNS drug reviews, 9(1), 97-140 (2003-02-22) Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation.Anatoly Kreinin et al.The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 12(8), 620-626 (2010-10-23) Moclobemide in patients with dementia and depression.R Amrein et al.Advances in neurology, 80, 509-519 (1999-07-20) A risk-benefit assessment of moclobemide in the treatment of depressive disorders.T R Norman et al.Drug safety, 12(1), 46-54 (1995-01-01) Moclobemide in the treatment of social phobia.D Nutt et al.International clinical psychopharmacology, 11 Suppl 3, 77-82 (1996-06-01) Antidepressant use in the elderly. Current status of nefazodone, venlafaxine and moclobemide.R J Goldberg Drugs & aging, 11(2), 119-131 (1997-08-01) Moclobemide.H Freeman Lancet (London, England), 342(8886-8887), 1528-1532 (1993-12-18) Antidepressant-like effect of the novel MAO inhibitor 2-(3,4-dimethoxy-phenyl)-4,5-dihydro-1H-imidazole (2-DMPI) in mice.Jardel Gomes Villarinho et al.Progress in neuro-psychopharmacology & biological psychiatry, 39(1), 31-39 (2012-04-25) Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.N P Nair et al.Journal of psychiatry & neuroscience : JPN, 18(5), 214-225 (1993-11-01) An update of recent moclobemide interaction data.J Dingemanse International clinical psychopharmacology, 7(3-4), 167-180 (1993-01-01) Improved statistical analysis of moclobemide dose effects on panic disorder treatment.Donald C Ross et al.European archives of psychiatry and clinical neuroscience, 260(3), 243-248 (2009-11-26) Antidepressive treatment with monoamine oxidase inhibitors and the occurrence of intraoperative hemodynamic events: a retrospective observational cohort study.Ingrid M M van Haelst et al.The Journal of clinical psychiatry, 73(8), 1103-1109 (2012-09-04) [The serotoninergic syndrome: moclobemide and citalopram].M Gumà et al.Medicina clinica, 113(17), 677-678 (2000-01-05) Moclobemide upregulated Bcl-2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular-regulated kinase pathway.Shih-Hwa Chiou et al.British journal of pharmacology, 148(5), 587-598 (2006-05-17) Monoclonal antibodies to lipopolysaccharide antigens of Salmonella enterica serotype Typhimurium DT104.Jennifer Ronholm et al.Hybridoma (2005), 30(1), 43-52 (2011-04-07) The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine.P Bech et al.Journal of affective disorders, 140(3), 253-259 (2012-03-03) Application of curve resolution algorithms in the study of drug photodegradation kinetics -- the example of moclobemide.Robert Skibiński et al.Journal of AOAC International, 95(3), 708-712 (2012-07-24) Moclobemide--placebo-controlled trials.T Silverstone International clinical psychopharmacology, 7(3-4), 133-136 (1993-01-01) Quantification of 4 antidepressants and a metabolite by LC-MS for therapeutic drug monitoring.Eva Choong et al.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 879(19), 1544-1550 (2011-04-29) Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shell.Daniel I Brierley et al.Journal of psychopharmacology (Oxford, England), 27(1), 98-108 (2012-10-19) Serotonin toxicity involving MDMA (ecstasy) and moclobemide.J L Pilgrim et al.Forensic science international, 215(1-3), 184-188 (2011-05-17) Evaluation of single-point sampling strategies for the estimation of moclobemide exposure in depressive patients.Anita Rakic Ignjatovic et al.Journal of clinical pharmacology, 51(5), 661-671 (2010-05-25) Death of a female cocaine user due to the serotonin syndrome following moclobemide-venlafaxine overdose.Małgorzata Kłys et al.Forensic science international, 184(1-3), e16-e20 (2009-01-10) Validated UPLC-MS/MS method for determination of moclobemide in human brain cell supernatant and its application to bidirectional transport study.Dai Li-Bo et al.Biomedical chromatography : BMC, 27(9), 1143-1149 (2013-04-26) Rat electropharmacograms of the flavonoids rutin and quercetin in comparison to those of moclobemide and clinically used reference drugs suggest antidepressive and/or neuroprotective action.Wilfried Dimpfel Phytomedicine : international journal of phytotherapy and phytopharmacology, 16(4), 287-294 (2009-03-24) Moclobemide monotherapy vs. combined therapy with valproic acid or carbamazepine in depressive patients: a pharmacokinetic interaction study.Anita Rakic Ignjatovic et al.British journal of clinical pharmacology, 67(2), 199-208 (2008-12-17) Moclobemide treatment of clozapine-induced hypersalivation: pilot open study.Anatoly Kreinin et al.Clinical neuropharmacology, 32(3), 151-153 (2009-06-02) Hypothermia in a combined intoxication with doxepin and moclobemide in an adolescent.Sven Armbrust et al.Forensic science international, 195(1-3), e1-e3 (2010-01-16) Fatal serotonin toxicity caused by moclobemide and fluoxetine overdose.Ming-Ling Wu et al.Chang Gung medical journal, 34(6), 644-649 (2011-12-27) RIMA--a new concept in the treatment of depression with moclobemide.R Amrein et al.International clinical psychopharmacology, 7(3-4), 123-132 (1993-01-01) [Seronin syndrome and cardiac arrest caused by high-dose moclobemide (case report)].N Cekmen et al.Anesteziologiia i reanimatologiia, (4)(4), 64-65 (2008-09-30) Clinical overview on moclobemide.J W Tiller Progress in neuro-psychopharmacology & biological psychiatry, 17(5), 703-712 (1993-09-01) [Serotonin syndrome in the course of drug-poisoning--case presentation].Magdalena Majewska et al.Przeglad lekarski, 68(8), 523-526 (2011-10-21) Moclobemide safety: monitoring a newly developed product in the 1990s.S Hilton et al.Journal of clinical psychopharmacology, 15(4 Suppl 2), 76S-83S (1995-08-01) Influence of antidepressant drugs on Ecto-nucleotide pyrophosphatase/phosphodiesterases (E-NPPs) from salivary glands of rats.Sandra Liana Henz et al.Archives of oral biology, 54(8), 730-736 (2009-05-29) Moclobemide exerts anti-inflammatory effect in lipopolysaccharide-activated primary mixed glial cell culture.A M Bielecka et al.Naunyn-Schmiedeberg's archives of pharmacology, 382(5-6), 409-417 (2010-09-03) Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study.Julia Sacher et al.Journal of psychiatry & neuroscience : JPN, 36(6), 375-382 (2011-04-06) Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide.M Versiani Journal of affective disorders, 51(3), 323-332 (1999-05-20) Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome.Sera Tort et al.The Cochrane database of systematic reviews, 4(4), CD009807-CD009807 (2012-04-20) [Obstructive sleep apnoea syndrome as the cause of atypical depression].F U Lang et al.Fortschritte der Neurologie-Psychiatrie, 79(9), 531-534 (2011-08-27) Moclobemide: evolution, pharmacodynamic, and pharmacokinetic properties.Udo Bonnet CNS drug reviews, 8(3), 283-308 (2002-09-28) Moclobemide: a paradigm of research in clinical psychopharmacology.J Angst et al.International clinical psychopharmacology, 11 Suppl 3, 3-7 (1996-06-01) Pharmacology of moclobemide.W Haefely et al.Clinical neuropharmacology, 16 Suppl 2, S8-18 (1993-01-01) The role of moclobemide in endogenous depression: a survey of recent data.B Woggon International clinical psychopharmacology, 7(3-4), 137-139 (1993-01-01) Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.Zdenek Fisar et al.Neuro endocrinology letters, 31(5), 645-656 (2011-01-05)

备注